Denmark leads the way in clinical trials with more than 4,700 so far. Sweden has run over 3,200 trials. These numbers reflect the progressive biotech industry in the ...

Between 2010 and 2014, 37 new molecular entities were approved by the FDA for the treatment of cancer; and between 1995 and 1999, only 20 such agents were approved. M...

The three major brain hallmarks of Alzheimer’s disease (AD) are extracellular amyloid plaques, axonal degeneration and intraneuronal neurofibrillary tangles, which ca...

New US Food and Drug Administration (FDA) draft guidance addresses when and how to evaluate drugs for the potential to impair driving ability, an issue that arises du...